By
LONDON: The German company will pay $4.6 billion including debt for Lincare, a specialist in respiratory gases. That is a full-looking 9.3 times EBITDA and synergies will be limited.
But Linde boosts its US footprint and secures a route to growth outside its consolidated core market.
More Stories



















Comments
Comments are closed for this article.